Trial updateRetina
A Phase I Study of GenSci148 Intravitreal Injection for Neovascular Age-related Macular Degeneration, Diabetic Macular Edema and Retinal Vein Occlusion
Not yet recruiting. Phase 1. Registered enrolment: 60. Changchun GeneScience Pharmaceutical Co., Ltd.
Why it matters
Track this study through NCT07817615. No results are posted in this registry record.
The study at a glance
- Registry status
- Not yet recruiting
- Phase
- Phase 1
- Registered enrolment
- 60
- Results posted
- No
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
Keep in mind
Registry information describes the study; recruitment status alone does not establish efficacy or safety.